GLP-1s are linked to a broad range of adverse events — largely gastrointestinal, metabolic, and psychological — across indications, according to analysis of FDA reporting.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-data-reveal-different-risks-glp-1s-2026a1000a4h?src=rss
Author :
Publish date : 2026-04-03 02:33:00
Copyright for syndicated content belongs to the linked Source.
